Literature DB >> 8356897

Effect of a long-lasting gonadotrophin hormone-releasing hormone agonist in six cases of severe male paraphilia.

F Thibaut1, B Cordier, J M Kuhn.   

Abstract

Six men with severe paraphilia had been treated with depot gonadotrophin luteinizing releasing hormone analogue (GnRHa) (triptorelin 3.75 mg per month intramuscularly). In 5 cases, the treatment ended their deviant sexual behavior and markedly decreased their sexual fantasies and activities without further significant side effects than those related to hypoandrogenism. This clinical improvement was parallel to the gradual decrease of plasma testosterone level to castration values within the first month. The beneficial effect of this treatment had been maintained at follow-up varying from 7 months to 3 years. One patient interrupted the treatment at the end of the first year and relapsed within 10 weeks. GnRHa treatment, which leads to reversible castration, may constitute a promising treatment of paraphilic behavior and may favor the possibility of concurrent psychotherapy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8356897     DOI: 10.1111/j.1600-0447.1993.tb03402.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  9 in total

1.  Effects of surgical and chemical castration on spatial learning ability in relation to cell proliferation and apoptosis in hippocampus.

Authors:  Mal-Soon Shin; Kyung Jin Chung; Il-Gyu Ko; Sang-Hoon Kim; Jun-Jang Jin; Sung-Eun Kim; Jae-Min Lee; Eun-Sang Ji; Tae-Woon Kim; Han-Sam Cho; Chang Hee Kim; Young-Sam Cho; Chang-Ju Kim; Khae-Hawn Kim
Journal:  Int Urol Nephrol       Date:  2016-01-18       Impact factor: 2.370

2.  [Failure of a study in forensic psychiatric hospitals : Clinical trial to investigate the additive effect of triptorelin on the efficacy of psychotherapy].

Authors:  Peer Briken; Jürgen L Müller; Wolfgang Berner; Rolf-Hasso Bödeker; Jochen Vollmann; Christian Kasperk; Matthias Koller
Journal:  Nervenarzt       Date:  2017-05       Impact factor: 1.214

Review 3.  Current concepts in the pharmacotherapy of paraphilias.

Authors:  Frederico D Garcia; Florence Thibaut
Journal:  Drugs       Date:  2011-04-16       Impact factor: 9.546

Review 4.  The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the treatment of adolescent sexual offenders with paraphilic disorders.

Authors:  Florence Thibaut; John M W Bradford; Peer Briken; Flora De La Barra; Frank Häßler; Paul Cosyns
Journal:  World J Biol Psychiatry       Date:  2015-11-23       Impact factor: 4.132

Review 5.  The Biological Treatment of Paraphilic Disorders: an Updated Review.

Authors:  Brian J Holoyda; Denise C Kellaher
Journal:  Curr Psychiatry Rep       Date:  2016-02       Impact factor: 5.285

Review 6.  Pharmacologic treatment of sex offenders with paraphilic disorder.

Authors:  Frederico Duarte Garcia; Heloise Garcia Delavenne; Alessandra de Fátima Almeida Assumpção; Florence Thibaut
Journal:  Curr Psychiatry Rep       Date:  2013-05       Impact factor: 5.285

7.  Therapeutic Effects of Leuprorelin (Leuprolide Acetate) in Sexual Offenders with Paraphilia.

Authors:  Jong Hyuk Choi; Jae Woo Lee; Jang Kyu Lee; Soyeong Jang; Mi Yoo; Dae-Bo Lee; Jeong-Won Hong; Il Suk Noh; Myung Ho Lim
Journal:  J Korean Med Sci       Date:  2018-07-23       Impact factor: 2.153

8.  A Case of Paraphilia with Osteoporosis and Administered with Depot Leuprorelin.

Authors:  Dohee Kim; Kyoung Min Kim; Myung Ho Lim
Journal:  Medicina (Kaunas)       Date:  2019-10-20       Impact factor: 2.430

9.  A case of mental retardation with paraphilia treated with depot leuprorelin.

Authors:  Woo Sung Park; Kyung Min Kim; Yong Woo Jung; Myung Ho Lim
Journal:  J Korean Med Sci       Date:  2014-09-02       Impact factor: 2.153

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.